BWI: GlaxoSmithKline Pharmaceuticals Net Sales up 9.3%, PBT Grows by 7.9% in First Quarter of FY 2009

Press release from Business Wire India
Source: GlaxoSmithKline Pharmaceuticals Limited
Tuesday, April 28, 2009 12:38 PM IST (07:08 AM GMT)
Editors: General: Consumer interest, Economy; Business: Banking & financial services, Business services, Financial Analyst, Healthcare, biotechnology & pharmaceutical, Stock exchanges; Healthcare
Release no: 19805
--------------------------------------------------
GlaxoSmithKline Pharmaceuticals Net Sales up 9.3%, PBT Grows by 7.9% in First Quarter of FY 2009


Mumbai, Maharashtra, India, Tuesday, April 28, 2009 -- (Business Wire India) -- GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended 31st March 2009. The Company has posted a Net Sales growth of 9.3% compared to the previous quarter, while Profit Before Tax has grown by 7.9%, on a comparable basis.

Commenting on the performance during the quarter, Dr. Hasit B. Joshipura, Managing Director, said "The Company's major products in the Priority range, including vaccines, registered good growth. During the quarter under review, we launched Cervarix, our vaccine for protecting women against Cervical Cancer and the initial response for the same has been encouraging".

About GlaxoSmithKline:

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk-india.com.

To view the Unaudited Financial Results, please click on the link given below:

Unaudited Financial Results 2009
For picture(s)/data to illustrate this release click below:

http://www.BusinessWireIndia.com/attachments/UNAUDITED FINANCIAL RESULTS 2009.pdf
UNAUDITED FINANCIAL RESULTS 2009.pdf


CONTACT DETAILS
Rupali Kalav, Manager, Corporate Communications, GlaxoSmithKline Pharmaceuticals Limited, +91 22 24959208, rupali.v.kalav@gsk.com

KEYWORDS
CONSUMER, ECONOMY, BANKING, BUSINESS SERVICES, Financial Analyst, HEALTHCARE, STOCK EXCHANGES, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com